|
1
|
Ahmed S and Oropello JM: Critical care
issues in oncological surgery patients. Crit Care Clin. 26:93–106.
2010. View Article : Google Scholar
|
|
2
|
Cooksley TJ and Haji-Michael P:
Post-operative critical care management of patients undergoing
cytoreductive surgery and heated intraperitoneal chemotherapy
(HIPEC). World J Surg Oncol. 9:1692011. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Namendys-Silva SA, Texcocano-Becerra J and
Herrera-Gómez A: Prognostic factors in critically ill patients with
solid tumor admitted to an oncological intensive care unit. Anaesth
Intensive Care. 38:317–324. 2010.PubMed/NCBI
|
|
4
|
López-Basave HN, Morales-Vásquez F, Ruiz
Molina JM, et al: Morbidity and mortality of cytoreductive surgery
with hyperthermic intraperitoneal chemotherapy: national cancer
institute, Mexico city, Mexico. ISRN Oncol.
2011:5263842011.PubMed/NCBI
|
|
5
|
Namendys-Silva SA, González-Herrera MO,
García-Guillén FJ, Texcocano-Becerra J and Herrera-Gómez A: Outcome
of critically ill patients with hematological malignancies. Ann
Hematol. 92:699–705. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
González-Moreno S, González-Bayón LA and
Ortega-Pérez G: Hyperthermic intraperitoneal chemotherapy:
Rationale and technique. World J Gastrointest Oncol. 2:68–75. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Dripps RD: New classification of physical
status. Anesthesiol. 24:1111963.
|
|
8
|
Vincent JL, Moreno R, Takala J, et al: The
SOFA (Sepsis-related Organ Failure Assessment) score to describe
organ dysfunction/failure. On behalf of the Working Group on
Sepsis-Related Problems of the European Society of Intensive Care
Medicine. Intensive Care Med. 22:707–710. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Knaus WA, Draper EA, Wagner DP and
Zimmerman JE: APACHE II: a severity of disease classification
system. Crit Care Med. 13:818–829. 1985. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Schmidt C, Moritz S, Rath S, Grossmann E,
Wiesenack C, Piso P, Graf B and Bucher M: Perioperative management
of patients with cytoreductive surgery for peritoneal
carcinomatosis. J Surg Oncol. 100:297–301. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Corcoran T, Rhodes JE, Clarke S, et al:
Perioperative fluid management strategies in major surgery: a
stratified meta-analysis. Anesth Analg. 114:640–651. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Raspe C, Piso P, Wiesenack C and Bucher M:
Anesthetic management in patients undergoing hyperthermic
chemotherapy. Curr Opin Anaesthesiol. 25:348–355. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Schmidt C, Creutzenberg M, Piso P,
Hobbhahn J and Bucher M: Peri-operative anaesthetic management of
cytoreductive surgery with hyperthermic intraperitoneal
chemotherapy. Anaesthesia. 63:389–395. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Arakelian E, Gunningberg L, Larsson J,
Norlén K and Mahteme H: Factors influencing early postoperative
recovery after cytoreductive surgery and hyperthermic
intraperitoneal chemotherapy. Eur J Surg Oncol. 37:897–903. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Rothfield KP and Crowley K: Anesthesia
considerations during cytoreductive surgery and hyperthermic
intraperitoneal chemotherapy. Surg Oncol Clin N Am. 21:533–541.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Smeenk RM, Verwaal V and Zoetmulder FA:
Toxicity and mortality of cytoreduction and intraoperative
hyperthermic intraperitoneal chemotherapy in pseudomyxoma peritonei
- a report of 103 procedures. Eur J Surg Oncol. 32:186–190. 2006.
View Article : Google Scholar
|
|
17
|
Murphy EM, Sexton R and Moran BJ: Early
results of surgery in 123 patients with pseudomyxoma peritonei from
a perforated appendiceal neoplasm. Dis Colon Rectum. 50:37–42.
2007. View Article : Google Scholar
|
